NL7710389A - PROCESS FOR PREPARING SUBSTITUTED 6-PHENYL-1,2,4-TRIAZOLE / 4,3-B / PYRIDAZINS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT. - Google Patents
PROCESS FOR PREPARING SUBSTITUTED 6-PHENYL-1,2,4-TRIAZOLE / 4,3-B / PYRIDAZINS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.Info
- Publication number
- NL7710389A NL7710389A NL7710389A NL7710389A NL7710389A NL 7710389 A NL7710389 A NL 7710389A NL 7710389 A NL7710389 A NL 7710389A NL 7710389 A NL7710389 A NL 7710389A NL 7710389 A NL7710389 A NL 7710389A
- Authority
- NL
- Netherlands
- Prior art keywords
- pyridazins
- triazole
- phenyl
- components
- active component
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/08—Preparation of carboxylic acids or their salts, halides or anhydrides from nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/12—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/725,597 US4230705A (en) | 1976-09-22 | 1976-09-22 | 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety |
| US73039576A | 1976-10-07 | 1976-10-07 | |
| US73547576A | 1976-10-26 | 1976-10-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL7710389A true NL7710389A (en) | 1978-03-28 |
Family
ID=27419081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7710389A NL7710389A (en) | 1976-09-22 | 1977-09-22 | PROCESS FOR PREPARING SUBSTITUTED 6-PHENYL-1,2,4-TRIAZOLE / 4,3-B / PYRIDAZINS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT. |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS5340798A (en) |
| AR (2) | AR218036A1 (en) |
| AT (1) | AT360034B (en) |
| AU (1) | AU513760B2 (en) |
| BG (1) | BG29287A3 (en) |
| CA (1) | CA1080712A (en) |
| DD (1) | DD132586A5 (en) |
| DE (1) | DE2741763A1 (en) |
| DK (1) | DK417377A (en) |
| ES (3) | ES462543A1 (en) |
| FI (1) | FI772802A7 (en) |
| FR (1) | FR2442848A1 (en) |
| GB (1) | GB1589237A (en) |
| GR (1) | GR71699B (en) |
| LU (1) | LU78150A1 (en) |
| NL (1) | NL7710389A (en) |
| NO (1) | NO773245L (en) |
| PT (1) | PT67067B (en) |
| RO (1) | RO72226A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0036711A3 (en) * | 1980-03-22 | 1982-06-09 | Fbc Limited | Pesticidal heterocyclic compounds, processes for preparing them, compositions containing them, and their use |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR70309B (en) * | 1979-10-29 | 1982-09-08 | Dow Chemical Co | |
| FR2473522A1 (en) * | 1980-01-16 | 1981-07-17 | Synthelabo | NOVEL DIHYDRO-2,3 IMIDAZO (1,2-B) PYRIDAZINE SUBSTITUTED DERIVATIVES AND MEDICAMENTS, PARTICULARLY USEFUL AS ANTIDEPRESSANTS, CONTAINING THEM |
| DE3217325A1 (en) * | 1982-05-08 | 1983-11-10 | Hoechst Ag, 6230 Frankfurt | 3-AMINO-6-ARYL-1,2,4-TRIAZOLO (4,3-B) -PYRIDAZINE, THEIR PRODUCTION AND USE |
| US4487930A (en) * | 1982-09-07 | 1984-12-11 | The Dow Chemical Company | 6-[(Cyclic amino)alkylamino]-tetrahydrotriazolo[3,4-a]phthalazines |
| FR2562071B1 (en) * | 1984-03-30 | 1986-12-19 | Sanofi Sa | TRIAZOLO (4,3-B) PYRIDAZINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| US4654343A (en) * | 1985-10-31 | 1987-03-31 | American Cyanamid Company | N-substituted-N[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas |
| US4767765A (en) * | 1985-10-31 | 1988-08-30 | American Cyanamid Company | N-substituted-N-[3-(1,2,4-triazolo-[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas |
| WO1998004559A2 (en) * | 1996-07-25 | 1998-02-05 | Merck Sharp & Dohme Limited | Substituted triazolo-pyridazine derivatives as ligands for gaba receptors |
| EP1047697A1 (en) * | 1998-01-14 | 2000-11-02 | MERCK SHARP & DOHME LTD. | Triazolo-pyridazine derivatives as ligands for gaba receptors |
| GB9801234D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
| GB9801202D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
| GB9801208D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
| PL341652A1 (en) * | 1998-01-21 | 2001-04-23 | Merck Sharp & Dohme | Derivatives of triazolopyridazine as ligands for gaba receptors |
| GB9801210D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
| GB9801397D0 (en) * | 1998-01-22 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
| GB9801538D0 (en) | 1998-01-23 | 1998-03-25 | Merck Sharp & Dohme | Pharmaceutical product |
| US7645756B2 (en) * | 2004-02-18 | 2010-01-12 | Banyu Pharmaceutical Co. Ltd. | Nitrogenous fused heteroaromatic ring derivative |
| EP3548033B1 (en) * | 2016-11-28 | 2024-04-10 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| AU2019278814B2 (en) | 2018-05-30 | 2025-12-18 | Praxis Precision Medicines, Inc. | Ion channel modulators |
| EA202092908A1 (en) | 2018-09-28 | 2021-05-14 | Праксис Пресижн Медсинз, Инк. | ION CHANNEL MODULATORS |
| US11773099B2 (en) | 2019-05-28 | 2023-10-03 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| US11505554B2 (en) | 2019-05-31 | 2022-11-22 | Praxis Precision Medicines, Inc. | Substituted pyridines as ion channel modulators |
| JP7712932B2 (en) * | 2019-12-18 | 2025-07-24 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | LIN28 INHIBITORS AND METHODS OF USE THEREOF |
-
1977
- 1977-08-16 CA CA284,806A patent/CA1080712A/en not_active Expired
- 1977-08-19 GR GR54197A patent/GR71699B/el unknown
- 1977-09-07 AR AR269126A patent/AR218036A1/en active
- 1977-09-16 DE DE19772741763 patent/DE2741763A1/en not_active Withdrawn
- 1977-09-20 BG BG037371A patent/BG29287A3/en unknown
- 1977-09-20 LU LU78150A patent/LU78150A1/xx unknown
- 1977-09-20 RO RO7791618A patent/RO72226A/en unknown
- 1977-09-21 DK DK417377A patent/DK417377A/en unknown
- 1977-09-21 AT AT677577A patent/AT360034B/en not_active IP Right Cessation
- 1977-09-21 AU AU28995/77A patent/AU513760B2/en not_active Expired
- 1977-09-21 NO NO773245A patent/NO773245L/en unknown
- 1977-09-22 FR FR7728639A patent/FR2442848A1/en active Pending
- 1977-09-22 DD DD7700201157A patent/DD132586A5/en unknown
- 1977-09-22 NL NL7710389A patent/NL7710389A/en not_active Application Discontinuation
- 1977-09-22 FI FI772802A patent/FI772802A7/en not_active Application Discontinuation
- 1977-09-22 PT PT67067A patent/PT67067B/en unknown
- 1977-09-22 GB GB39619/77A patent/GB1589237A/en not_active Expired
- 1977-09-22 JP JP11344877A patent/JPS5340798A/en active Pending
- 1977-09-22 ES ES462543A patent/ES462543A1/en not_active Expired
-
1978
- 1978-12-18 AR AR274489A patent/AR217886A1/en active
-
1979
- 1979-02-16 ES ES477800A patent/ES477800A1/en not_active Expired
- 1979-02-16 ES ES477799A patent/ES477799A1/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0036711A3 (en) * | 1980-03-22 | 1982-06-09 | Fbc Limited | Pesticidal heterocyclic compounds, processes for preparing them, compositions containing them, and their use |
Also Published As
| Publication number | Publication date |
|---|---|
| PT67067B (en) | 1979-02-19 |
| AU2899577A (en) | 1979-03-29 |
| AU513760B2 (en) | 1980-12-18 |
| JPS5340798A (en) | 1978-04-13 |
| DE2741763A1 (en) | 1978-03-23 |
| DK417377A (en) | 1978-03-23 |
| AR217886A1 (en) | 1980-04-30 |
| NO773245L (en) | 1978-03-28 |
| ES477800A1 (en) | 1979-10-16 |
| FI772802A7 (en) | 1978-03-23 |
| DD132586A5 (en) | 1978-10-11 |
| ATA677577A (en) | 1980-05-15 |
| FR2442848A1 (en) | 1980-06-27 |
| BG29287A3 (en) | 1980-10-15 |
| ES462543A1 (en) | 1979-06-16 |
| AT360034B (en) | 1980-12-10 |
| LU78150A1 (en) | 1978-01-23 |
| RO72226A (en) | 1982-09-09 |
| PT67067A (en) | 1977-10-01 |
| GR71699B (en) | 1983-06-21 |
| ES477799A1 (en) | 1980-04-01 |
| AR218036A1 (en) | 1980-05-15 |
| GB1589237A (en) | 1981-05-07 |
| CA1080712A (en) | 1980-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL7710389A (en) | PROCESS FOR PREPARING SUBSTITUTED 6-PHENYL-1,2,4-TRIAZOLE / 4,3-B / PYRIDAZINS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT. | |
| NL7712567A (en) | PROCESS FOR PREPARING TRI-SUBSTITUTED 1-PHENYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE COMPOUNDS, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AS AN ACTIVE COMPONENT. | |
| NL7707750A (en) | METHOD FOR PREPARING SULFATED OLIGOSACCHARIDES, AND PHARMACEUTICAL PREPARATIONS INCLUDING THESE COMPOUNDS AS AN ACTIVE COMPONENT. | |
| NL8103768A (en) | HETEROCYCLIC COMPOUNDS, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AS AN ACTIVE COMPONENT. | |
| NL7907583A (en) | HETEROCYCLIC COMPOUNDS, IN PARTICULAR INDOOL COMPOUNDS, METHODS FOR PREPARING THE SAME, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AS AN ACTIVE COMPONENT. | |
| NL7502664A (en) | PROCESS FOR PREPARING ANTIBIOTIC ACULEACINS, AND PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT. | |
| NL7702548A (en) | PROCESS FOR PREPARING 3,7-DIG-SUBSTITUTED -3-CEFEM-4-CARBONIC ACID COMPOUNDS, AND PHARMA-CEUTIC PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT. | |
| NL7708741A (en) | PROCESS FOR THE PREPARATION OF PROSTANIC ACID DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AS AN ACTIVE COMPONENT. | |
| NL7700379A (en) | PROCESS FOR PREPARING ANTHRACYCLINEGLYCOSIDES AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT. | |
| NL7705584A (en) | PROCESS FOR PREPARING TERTIARY IMIDAZOLY ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT. | |
| NL7709697A (en) | METHOD FOR PREPARING THIAZOLIDINE DERIVATIVES, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AS AN ACTIVE COMPONENT. | |
| NL7603193A (en) | PROCESS FOR THE PREPARATION OF ACYCLIC, ALICYCLIC AND AROMATIC N-SUBSTITUATED HALOGEN-2 -PYRROLIDINONES WITH HERBICIDE ACTION AND HERBICIDE PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT. | |
| NL7706064A (en) | PROCESS FOR THE PREPARATION OF HETEROCYCLICAL COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT. | |
| NL7613041A (en) | PROCESS FOR PREPARING PICOLIC ACID DERIVATIVES AND PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT. | |
| NL7705141A (en) | PROCESS FOR PREPARING PROSTAGLANDIN DERIVATIVES, AND PHARMACEUTICAL PREPARATIONS CONTAINING THIS COMPONENT AS AN ACTIVE COMPONENT. | |
| NL7708982A (en) | METHOD FOR PREPARING DIHYDRO-OXO-NICOTINIC ACIDS, AND PHARMACEUTICAL PREPARATIONS CONTAINING THIS COMPOUND AS AN ACTIVE COMPONENT. | |
| NL7711414A (en) | PROCESS FOR THE PREPARATION OF N-SUBSTITUTED LACTAMS, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AS AN ACTIVE COMPONENT. | |
| NL7409752A (en) | PROCESS FOR PREPARING 1,4-DIGES SUBSTITUTE PIPERIDINS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS ACTIVE COMPONENTS. | |
| NL7707150A (en) | PROCESS FOR THE PREPARATION OF 2-LOWER ALKYL-7-SUBSTITUATED-2 OR 3-CEFEM-4-CARBONIC ACID COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT. | |
| NL7613334A (en) | PROCESS FOR PREPARING CARBAMATE-SULPHENYL-CARBAMOYL FLUORIDE COMPOUNDS AND PESTICIAN PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT. | |
| NL7412302A (en) | PROCESS FOR THE PREPARATION OF PYRAZOLIUM COMPOUNDS AND HERBICIDE PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT. | |
| NL7714063A (en) | PROCESS FOR THE PREPARATION OF IMIDAZOLINS AND PESTICIDE PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT. | |
| NL7708377A (en) | METHOD FOR PREPARING PHARMACOLOGICALLY ACTIVE COMPOUNDS AND PREPARATIONS INCLUDING THESE COMPOUNDS AS AN ACTIVE COMPONENT. | |
| NL7601502A (en) | PROCESS FOR PREPARING PYRETHROIDS, AS WELL AS INSECTICIDES AND ACARICIDES CONTAINING THESE COMPONENTS AS ACTIVE COMPONENTS. | |
| NL7602520A (en) | PROCESS FOR PREPARING PYRAZOLIUM COMPONENTS WITH HERBICIDE AND FUNGICIDE PROPERTIES, AS WELL AS HERBICIDE AND FUNGICIDE PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BV | The patent application has lapsed |